Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,236 public trials 880 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Active, Not Recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +37 more
Locations
  • HonorHealth Phoenix, Arizona, United States
  • HonorHealth Tempe, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Huntington Beach Huntington Beach, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • University of Louisville Louisville, Kentucky, United States
  • New York Oncology Hematology Pc. Clifton Park, New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

The Engaging Primary Care in Cancer Survivorship (EPICS) Study

NCT04745754

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Kaiser Permanente Orange County Anaheim/Irvine Medical Center Oncology Clinics Anaheim, California, United States
  • Kaiser Permanente Baldwin Park Medical Center Oncology Clinic Baldwin Park, California, United States
  • Kaiser Permanente Downey/Bellflower Medical Center Oncology Clinics Downey, California, United States
  • Kaiser Permanente Fontana Medical Center Oncology Clinic Fontana, California, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients

NCT03829462

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Centre Antoine Lacassagne Nice, Alpes-Maritimes, France
  • Centre François Baclesse Caen, Basse-Normandie, France
  • Hôpital Pontchaillou Rennes, Ile Et Vilaine, France
  • Hôpital Robert Debré Reims, Marne, France
View Trial Details
Active, Not Recruiting

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

NCT06328738

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations
  • BRCR Medical Center Inc. Plantation, Florida, United States
  • Washington University St Louis, Missouri, United States
  • NEXT Virginia Fairfax, Virginia, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 31 locations
View Trial Details

Related conditions